A. Mitchell

发表

Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.

M. Hernán, S. Hernández-Díaz, M. Werler, 2002, American journal of epidemiology.

Prevalence and characteristics of opioid use in the US adult population

A. Mitchell, D. Kaufman, S. Cook, 2008, PAIN.

Birth defects and vaginal spermicides.

S. Shapiro, A. Mitchell, S. Helmrich, 1982 .

Case-control study of periconceptional folic acid supplementation and oral clefts.

W. Willett, M. Werler, A. Mitchell, 1996, American journal of epidemiology.

Effect of questionnaire design on recall of drug exposure in pregnancy.

S. Shapiro, A. Mitchell, L. Cottler, 1986, American journal of epidemiology.

Use of decongestants during pregnancy and the risk of birth defects.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2013, American journal of epidemiology.

Vasoactive exposures during pregnancy and risk of microtia.

M. Werler, A. Mitchell, C. Moore, 2013, Birth defects research. Part A, Clinical and molecular teratology.

Influenza Vaccination Coverage During Pregnancy - Selected Sites, United States, 2005-06 Through 2013-14 Influenza Vaccine Seasons.

A. Mitchell, Stephen M Kerr, Carla M Van Bennekom, 2016, MMWR. Morbidity and mortality weekly report.

Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects.

A. Mitchell, K. Jones, C. Chambers, 2013, Vaccine.

Use of a job-exposure matrix to assess occupational exposures in relation to birth defects.

M. Werler, A. Mitchell, H. Frumkin, 2000, Journal of occupational and environmental medicine.

Special Applications of Pharmacoepidemiology

Robert T. Chen, A. Mitchell, S. Normand, 2013, Textbook of Pharmacoepidemiology.

Maternal exposure to hydroxychloroquine and birth defects

M. Werler, A. Mitchell, J. Reefhuis, 2021, Birth defects research.

Oseltamivir exposure in pregnancy and the risk of specific birth defects.

A. Mitchell, Stephen M Kerr, Carla M Van Bennekom, 2019, Birth defects research.

Application of data screening to drug exposure in large risk factor studies of birth defects.

M. Werler, A. Mitchell, M. Anderka, 2015, Birth defects research. Part A, Clinical and molecular teratology.

Maternal Hypertension, Medication Use, and Hypospadias in the National Birth Defects Prevention Study

M. Werler, A. Mitchell, L. McNutt, 2014, Obstetrics and gynecology.

A description of spina bifida cases and co‐occurring malformations, 1976–2011

M. Werler, A. Mitchell, L. Demmer, 2014, American journal of medical genetics. Part A.

Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007.

M. Werler, A. Mitchell, M. Canfield, 2013, Paediatric and perinatal epidemiology.

Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2012, Birth defects research. Part A, Clinical and molecular teratology.

Use of topiramate in pregnancy and risk of oral clefts.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2012, American journal of obstetrics and gynecology.

Case–control studies for identifying novel teratogens

M. Werler, A. Mitchell, C. Louik, 2011, American journal of medical genetics. Part C, Seminars in medical genetics.

Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects.

A. Mitchell, Tonia C Carter, P. Romitti, 2011, Birth defects research. Part A, Clinical and molecular teratology.

Herbal use before and during pregnancy.

A. Mitchell, M. Honein, C. Broussard, 2010, American journal of obstetrics and gynecology.

Decongestant use during pregnancy and its association with preterm delivery.

M. Werler, A. Mitchell, R. Hernandez, 2010, Birth defects research. Part A, Clinical and molecular teratology.

Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?

M. Werler, A. Mitchell, C. Moore, 2009, American journal of medical genetics. Part A.

Antihypertensive Medication Use During Pregnancy and the Risk of Cardiovascular Malformations

M. Werler, A. Mitchell, A. Lin, 2009, Hypertension.

Maternal exposure to statins and risk for birth defects: A case‐series approach

M. Werler, A. Mitchell, S. Rasmussen, 2008, American journal of medical genetics. Part A.

BSTETRICS ntifungal drugs and the risk of selected birth defects

M. Werler, A. Mitchell, P. Romitti, 2008 .

Maternal caffeine consumption and risk of cardiovascular malformations.

A. Mitchell, A. Lin, A. Correa, 2007, Birth defects research. Part A, Clinical and molecular teratology.

Use of over-the-counter medications during pregnancy.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2005, American journal of obstetrics and gynecology.

Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects.

S. Shapiro, A. Mitchell, L. Rosenberg, 1981, JAMA.

First‐trimester exposure to bupropion and risk of cardiac malformations

A. Mitchell, C. Louik, Stephen Kerr, 2014, Pharmacoepidemiology and drug safety.

Selective serotonin reuptake inhibitor use and risk of gestational hypertension.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2009, The American journal of psychiatry.

Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth Restriction

S. Hernández-Díaz, M. Werler, A. Mitchell, 2009, Journal of clinical psychopharmacology.

Recent trends in use of herbal and other natural products.

A. Mitchell, D. Kaufman, L. Rosenberg, 2005, Archives of internal medicine.

Trends and predictors of folic acid awareness and periconceptional use in pregnant women.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2011, American journal of obstetrics and gynecology.

The Use of Randomized Controlled Trials for Pharmacoepidemiology

A. Mitchell, S. Lesko, R. Reynolds, 2021, Textbook of Pharmacoepidemiology.

The Use of Randomized Controlled Trials for Pharmacoepidemiology Studies

A. Mitchell, S. Lesko, 2013 .

Use of postmenopausal hormone therapy since the Women's Health Initiative findings

A. Mitchell, D. Kaufman, L. Rosenberg, 2005, Pharmacoepidemiology and drug safety.

Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella.

A. Mitchell, K. O'Brien, B. Schwartz, 2001, Pediatrics.

Changes in sleep position during infancy: a prospective longitudinal assessment.

A. Mitchell, T. Heeren, C. Hunt, 1998, JAMA.

Maternal vitamin A supplementation in relation to selected birth defects.

M. Werler, A. Mitchell, L. Rosenberg, 1990, Teratology.

Lack of relation of oral clefts to diazepam use during pregnancy.

S. Shapiro, A. Mitchell, L. Rosenberg, 1983, The New England journal of medicine.

Birth defects in relation to Bendectin use in pregnancy. II. Pyloric stenosis.

S. Shapiro, A. Mitchell, L. Rosenberg, 1983, American journal of obstetrics and gynecology.

Selected Birth Defects in Relation to Caffeine‐Containing Beverages

S. Shapiro, A. Mitchell, L. Rosenberg, 1982, JAMA.

Characteristics of Persistent Diarrhea in a Community-Based Cohort of Young US Children

A. Mitchell, R. Vezina, D. Acheson, 2006, Journal of pediatric gastroenterology and nutrition.

Multivitamin supplementation and multiple births.

G. Shaw, C. Wasserman, M. Werler, 1997, American journal of medical genetics.

Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk

S. Hernández-Díaz, A. Mitchell, S. Gilboa, 2013, Pharmacoepidemiology and drug safety.

Prescription medication sharing.

A. Mitchell, 2008, American journal of public health.

Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature

A. Mitchell, S. Rasmussen, A. Lin, 2009, American journal of medical genetics. Part A.

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2007, The New England journal of medicine.

Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth.

M. Werler, A. Mitchell, K. Ahrens, 2014, Paediatric and perinatal epidemiology.

Proton-pump inhibitors and birth defects--some reassurance, but more needed.

A. Mitchell, 2010, The New England journal of medicine.

Risk of gestational hypertension in relation to folic acid supplementation during pregnancy.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2002, American journal of epidemiology.

Preconceptional Iron Intake and Gestational Diabetes Mellitus

M. Werler, A. Mitchell, A. Darling, 2016, International journal of environmental research and public health.

Maternal cigarette smoking during pregnancy in relation to oral clefts.

M. Werler, A. Mitchell, L. Rosenberg, 1990, American journal of epidemiology.

Renal function after short-term ibuprofen use in infants and children.

A. Mitchell, S. Lesko, 1997, Pediatrics.

Identification of Phthalates in Medications and Dietary Supplement Formulations in the United States and Canada

S. Hernández-Díaz, A. Mitchell, R. Hauser, 2011, Environmental health perspectives.

Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System.

A. Mitchell, K. Jones, C. Chambers, 2011, American journal of obstetrics and gynecology.

Use of herbal treatments in pregnancy.

A. Mitchell, Katherine E. Kelley, P. Gardiner, 2010, American journal of obstetrics and gynecology.

Folic acid antagonists during pregnancy and the risk of birth defects.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2000, The New England journal of medicine.

The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects

S. Shapiro, M. Werler, A. Mitchell, 1989, The New England journal of medicine.

Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Preterm delivery and specific malformations, a study from the case-control arm of VAMPSS.

A. Mitchell, C. Chambers, M. Schatz, 2016, Vaccine.

Influenza vaccine safety in pregnancy: can we identify exposures?

A. Mitchell, C. Chambers, Diana L. Johnson, 2013, Pharmacoepidemiology and Drug Safety.

The Safety of Acetaminophen and Ibuprofen Among Children Younger Than Two Years Old

A. Mitchell, S. Lesko, 1999, Pediatrics.

One-Carbon Cofactor Intake and Risk of Neural Tube Defects Among Women Who Meet Folic Acid Recommendations: A Multicenter Case-Control Study.

M. Werler, A. Mitchell, Krista S Crider, 2019, American journal of epidemiology.

Vasoactive exposures, vascular events, and hemifacial microsomia.

M. Werler, A. Mitchell, J. Mulliken, 2004, Birth defects research. Clinical and molecular teratology.

Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.

A. Mitchell, R. Xu, K. Jones, 2013, Vaccine.

Validity of Parental Reporting of Recent Episodes of Acute Otitis Media: A Slone Center Office-based Research (SCOR) Network Study

A. Mitchell, A. Ozonoff, R. Vezina, 2007, The Journal of the American Board of Family Medicine.

Diarrhea in American Infants and Young Children in the Community Setting: Incidence, Clinical Presentation and Microbiology

A. Mitchell, R. Vezina, D. Acheson, 2006, The Pediatric infectious disease journal.

Folic acid antagonist use before and during pregnancy and risk for selected birth defects

M. Werler, A. Mitchell, S. E. Parker, 2020, Birth defects research.

CDC Grand Rounds: Understanding the Causes of Major Birth Defects - Steps to Prevention.

A. Mitchell, S. Gilboa, J. Iskander, 2015, MMWR. Morbidity and mortality weekly report.

Reply to Journal Club Roundtable.

S. Hernández-Díaz, A. Mitchell, A. Margulis, 2013, American journal of obstetrics and gynecology.

Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.

A. Mitchell, R. Xu, K. Jones, 2016, Vaccine.

isks and safety of pandemic h 1 n 1 influenza vaccine in pregnancy : irth defects , spontaneous abortion , preterm delivery , and small for estational age infants

A. Mitchell, D. Chambersa, D. Johnsona, 2013 .

Knowledge and Practices Relating to the 2004 Acute Otitis Media Clinical Practice Guideline: A Survey of Practicing Physicians

A. Mitchell, R. Vezina, L. Vernacchio, 2006, The Pediatric infectious disease journal.

Association between prepregnancy maternal body mass index and the risk of having an infant with a congenital diaphragmatic hernia.

M. Werler, A. Mitchell, A. Tita, 2003, Birth defects research. Part A, Clinical and molecular teratology.

Concerning the American Academy of Pediatrics recommendation on sleep position for infants.

A. Mitchell, S. Orenstein, S. D. Ward, 1993, Pediatrics.

The use of cisapride in children

A. Mitchell, R. Friedman, G. V. Van Hare, 1999 .

Racial/ethnic disparities in the diagnosis of otitis media in infancy.

A. Mitchell, H. Hoffman, C. Hunt, 2004, International journal of pediatric otorhinolaryngology.

Frequency of Bed Sharing and its Relationship to Breastfeeding

A. Mitchell, H. Hoffman, C. Hunt, 2004, Journal of developmental and behavioral pediatrics : JDBP.

Gulf War veterans and hemifacial microsomia.

M. Werler, A. Mitchell, J. Sheehan, 2005, Birth defects research. Part A, Clinical and molecular teratology.

The management of propoxyphene poisoning.

A. Mitchell, F. Lovejoy, P. Goldman, 1974, The Journal of pediatrics.

Xylitol Prophylaxis for Acute Otitis Media: Tout de Suite?

A. Mitchell, 1998, Pediatrics.

First trimester maternal medication use in relation to gastroschisis.

S. Shapiro, M. Werler, A. Mitchell, 1992, Teratology.

Achieving a public health recommendation for preventing neural tube defects with folic acid.

M. Werler, A. Mitchell, C. Louik, 1999, American journal of public health.

Descriptive epidemiology of idiopathic clubfoot

M. Werler, A. Mitchell, J. Kasser, 2013, American journal of medical genetics. Part A.

Cough and Cold Medication Use by US Children, 1999–2006: Results From the Slone Survey

A. Mitchell, D. Kaufman, J. Kelly, 2008, Pediatrics.

Vitamin, fluoride, and iron use among US children younger than 12 years of age: results from the Slone Survey 1998-2007.

A. Mitchell, D. Kaufman, J. Kelly, 2011, Journal of the American Dietetic Association.

Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.

A. Mitchell, S. E. Parker, M. Anderka, 2018, Obstetrics and gynecology.

Use of Selective Serotonin-Reuptake Inhibitors During Pregnancy and the Risk of Clubfoot

M. Werler, A. Mitchell, M. Yazdy, 2014, Epidemiology.

Maternal Exposure to Amoxicillin and the Risk of Oral Clefts

S. Hernández-Díaz, A. Mitchell, Kueiyu Joshua Lin, 2012, Epidemiology.

Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects.

M. Werler, A. Mitchell, S. E. Parker, 2017, Annals of epidemiology.

Nausea and vomiting in pregnancy: maternal characteristics and risk factors.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2006, Paediatric and perinatal epidemiology.

Association of Vasoconstrictive Exposures with Risks of Gastroschisis and Small Intestinal Atresia

M. Werler, A. Mitchell, J. Sheehan, 2003, Epidemiology.

Demographic, reproductive, medical, and environmental factors in relation to gastroschisis.

S. Shapiro, M. Werler, A. Mitchell, 1992, Teratology.

Birth defects and vaginal spermicides.

S. Shapiro, A. Mitchell, S. Helmrich, 1982, JAMA.

Tetanus, diphtheria, and pertussis vaccine (Tdap) in pregnancy and risk of major birth defects in the offspring.

A. Mitchell, Stephen M Kerr, Carla M Van Bennekom, 2020, Birth defects research.

Accutane and pregnancy.

A. Mitchell, Carla M Van Bennekom, 2003, Journal of the American Academy of Dermatology.

Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

Sonia Hernández-Díaz, S. Hernández-Díaz, M. Werler, 2011, American journal of obstetrics and gynecology.

Periconceptional nonsteroidal anti‐inflammatory drug use, folic acid intake, and the risk of spina bifida

M. Werler, A. Mitchell, S. E. Parker, 2021, Birth defects research.

Safety of macrolides during pregnancy.

S. Hernández-Díaz, A. Mitchell, Kueiyu Joshua Lin, 2013, American journal of obstetrics and gynecology.

OBSTETRICS Safety of macrolides during pregnancy

S. Hernández-Díaz, A. Mitchell, Kueiyu Joshua Lin, 2013 .

Risk factors for congenital microcephaly in the pre-Zika era.

A. Mitchell, Stephen M Kerr, Carla M Van Bennekom, 2019, Birth defects research.

Infertility treatment--more risks and challenges.

A. Mitchell, 2002, The New England journal of medicine.

Vancomycin-associated shock and rash in newborn infants.

A. Mitchell, P. Lacouture, M. Epstein, 1987, The Journal of pediatrics.

A pregnancy-prevention program in women of childbearing age receiving isotretinoin.

A. Mitchell, C. Louik, C. V. Van Bennekom, 1995, New England Journal of Medicine.

Periconceptional Use of Opioids and the Risk of Neural Tube Defects

M. Werler, A. Mitchell, S. E. Parker, 2013, Obstetrics and gynecology.

The authors respond.

M. Werler, A. Mitchell, M. Yazdy, 2015, Epidemiology.

Multivitamin supplementation and risk of birth defects.

S. Shapiro, M. Werler, A. Mitchell, 1999, American journal of epidemiology.

Ipecac-induced emesis and reduction of plasma concentrations of drugs following accidental overdose in children.

A. Mitchell, F. Lovejoy, Y. Amitai, 1987, Pediatrics.

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.

A. Mitchell, D. Kaufman, L. Rosenberg, 2002, JAMA.

Maternal tea consumption during early pregnancy and the risk of spina bifida.

M. Werler, A. Mitchell, L. Demmer, 2012, Birth defects research. Part A, Clinical and molecular teratology.

Antifungal drugs and the risk of selected birth defects.

M. Werler, A. Mitchell, P. Romitti, 2008, American journal of obstetrics and gynecology.

Antifungal Drugs and the Risk of Selected Birth Defects

M. Werler, A. Mitchell, P. Romitti, 2010 .

Special Considerations in Studies of Drug‐induced Birth Defects

A. Mitchell, 2002 .

A study of adverse reaction algorithms in a drug surveillance program

S. Shapiro, A. Mitchell, F. Lovejoy, 1985, Clinical pharmacology and therapeutics.

Medication Use Among Children <12 Years of Age in the United States: Results From the Slone Survey

A. Mitchell, D. Kaufman, J. Kelly, 2009, Pediatrics.

An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial.

A. Mitchell, S. Lesko, 1995, JAMA.

Recent patterns of drug use in newborn intensive care.

A. Mitchell, S. Lesko, M. Epstein, 1990, The Journal of pediatrics.

Tolerability of oral xylitol solution in young children: implications for otitis media prophylaxis.

A. Mitchell, R. Vezina, L. Vernacchio, 2007, International journal of pediatric otorhinolaryngology.

Secular changes in sleep position during infancy: 1995-1998.

A. Mitchell, T. Heeren, C. Hunt, 2003, Pediatrics.

Use of antiepileptic medications in pregnancy in relation to risks of birth defects.

M. Werler, A. Mitchell, L. Holmes, 2011, Annals of epidemiology.

Medication use in pregnancy in relation to the risk of isolated clubfoot in offspring.

M. Werler, A. Mitchell, J. Kasser, 2014, American journal of epidemiology.

Demographic and Reproductive Factors Associated with Hemifacial Microsomia

M. Werler, A. Mitchell, J. Mulliken, 2004, The Cleft Palate-Craniofacial Journal.

Maternal medication use and risks of gastroschisis and small intestinal atresia.

M. Werler, A. Mitchell, J. Sheehan, 2002, American journal of epidemiology.

Total bilirubin level in relation to excipients in parenteral morphine sulfate administered to seriously ill newborn infants.

A. Mitchell, S. Lesko, 1994, Paediatric and perinatal epidemiology.

Drug utilization and reported adverse reactions in hospitalized children.

S. Shapiro, A. Mitchell, D. Slone, 1979, American journal of epidemiology.

Neural-tube defects.

M. Werler, A. Mitchell, R. Finnell, 2013 .

Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn

S. Hernández-Díaz, M. Werler, A. Mitchell, 2006, The New England journal of medicine.

Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study.

M. Werler, A. Mitchell, D. Gagnon, 2018, Birth defects research.

Assessment of antihistamine use in early pregnancy and birth defects.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2013, The journal of allergy and clinical immunology. In practice.

Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns.

A. Olshan, M. Werler, A. Mitchell, 1999, American journal of epidemiology.

Periconceptional folic acid exposure and risk of occurrent neural tube defects.

S. Shapiro, M. Werler, A. Mitchell, 1993, JAMA.

Maternal cigarette, alcohol, and coffee consumption in relation to risk of clubfoot.

M. Werler, A. Mitchell, J. Kasser, 2015, Paediatric and perinatal epidemiology.

Adverse drug reactions in children leading to hospital admission.

S. Shapiro, A. Mitchell, R. Kauffman, 1988, Pediatrics.

Risks to children from computed tomographic scan premedication.

S. Shapiro, A. Mitchell, D. Slone, 1982, JAMA.

When a Randomised Controlled Trial is Needed to Assess Drug Safety

A. Mitchell, S. Lesko, 1995, Drug safety.

Drug ingestions associated with miosis in comatose children.

A. Mitchell, F. Lovejoy, P. Goldman, 1976, The Journal of pediatrics.

Prepregnant weight in relation to risk of neural tube defects.

S. Shapiro, M. Werler, A. Mitchell, 1996, JAMA.

Hyperbilirubinemia following exposure to pancuronium bromide in newborns.

S. Shapiro, A. Mitchell, S. Lesko, 1990, Developmental pharmacology and therapeutics.

Risk of Stillbirth for Fetuses With Specific Birth Defects.

S. Hernández-Díaz, A. Mitchell, D. Roberts, 2019, Obstetrics and gynecology.

Maternal dietary glycemic intake and the risk of neural tube defects.

M. Werler, A. Mitchell, Simin Liu, 2010, American journal of epidemiology.

Nonsteroidal Antiinflammatory Drugs in Late Pregnancy and Persistent Pulmonary Hypertension of the Newborn

S. Hernández-Díaz, M. Werler, A. Mitchell, 2013, Pediatrics.

The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida.

M. Werler, A. Mitchell, S. E. Parker, 2013, American journal of obstetrics and gynecology.

Thiethylperazine (Torecan)-associated dystonic reactions in children.

A. Mitchell, F. Lovejoy, P. Lacouture, 1979, Pediatrics.

Low maternal alcohol consumption during pregnancy and oral clefts in offspring: the Slone Birth Defects Study.

M. Werler, A. Mitchell, C. Hayes, 2003, Birth defects research. Part A, Clinical and molecular teratology.

Medications as a Potential Source of Exposure to Phthalates in the U.S. Population

S. Hernández-Díaz, A. Mitchell, A. Calafat, 2008, Environmental health perspectives.

Neural tube defects in relation to use of folic acid antagonists during pregnancy.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2001, American journal of epidemiology.

Epidemiologic analysis of maternal factors and amniotic band defects.

M. Werler, A. Mitchell, C. Louik, 2003, Birth defects research. Part A, Clinical and molecular teratology.

Maternal alcohol use in relation to selected birth defects.

M. Werler, A. Mitchell, L. Rosenberg, 1991, American journal of epidemiology.

Xylitol Syrup for the Prevention of Acute Otitis Media

A. Mitchell, R. Vezina, S. Pelton, 2014, Pediatrics.

Debendox

A. Mitchell, L. Sheffield, I. Gordon, 1986 .

Asthma in pregnancy and its pharmacologic treatment.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Infant sleep position and associated health outcomes.

Howard J Hoffman, A. Mitchell, H. Hoffman, 2003, Archives of pediatrics & adolescent medicine.

Sleep position of low birth weight infants.

A. Mitchell, H. Hoffman, C. Hunt, 2003, Pediatrics.

Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Gestational Hypertension

S. Hernández-Díaz, M. Werler, A. Mitchell, 2005, Epidemiology.

Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.

A. Mitchell, C. Louik, 2003, Obstetrics and gynecology.

The Use of Randomized Controlled Trials in Pharmacoepidemiology

A. Mitchell, S. Lesko, T. Staa, 2019, Pharmacoepidemiology.

Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants.

S. Shapiro, A. Mitchell, S. Lesko, 1986, The New England journal of medicine.

Periconceptional multivitamin use and infant birth weight disparities.

M. Werler, A. Mitchell, H. Burris, 2010, Annals of epidemiology.

Pseudoephedrine Use Among US Children, 1999–2006: Results From the Slone Survey

A. Mitchell, D. Kaufman, J. Kelly, 2008, Pediatrics.

Maternal genitourinary infections and the risk of gastroschisis.

M. Werler, A. Mitchell, M. Yazdy, 2014, American journal of epidemiology.

Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997–2011

M. Werler, A. Mitchell, S. Gilboa, 2019, Birth defects research.

Adhesive tape remover pads: a risk to the newborn?

A. Mitchell, S. Lesko, P. Lacouture, 1989, American journal of diseases of children.

Gestational hypertension in pregnancies supported by infertility treatments: role of infertility, treatments, and multiple gestations.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2007, Fertility and sterility.

Antibiotics and oral contraceptive failure - a case-crossover study.

S. Hernández-Díaz, A. Mitchell, L. de Jong-van den Berg, 2011, Contraception.

Predictors of recall certainty of dates of analgesic medication use in pregnancy

M. Werler, A. Mitchell, R. Radin, 2013, Pharmacoepidemiology and drug safety.

Drug certainty‐response in interview‐based studies

S. Hernández-Díaz, M. Werler, A. Mitchell, 2011, Pharmacoepidemiology and drug safety.

Case-crossover and case-time-control designs in birth defects epidemiology.

M. Hernán, S. Hernández-Díaz, M. Werler, 2003, American journal of epidemiology.

Association of Clomiphene and Assisted Reproductive Technologies With the Risk of Neural Tube Defects.

M. Werler, A. Mitchell, S. E. Parker, 2016, American journal of epidemiology.

Erythromycin use during pregnancy in relation to pyloric stenosis.

M. Werler, A. Mitchell, C. Louik, 2002, American journal of obstetrics and gynecology.

Ovulation induction and risk of neural tube defects

S. Shapiro, M. Werler, A. Mitchell, 1994, The Lancet.

Maternal exposure to spermicides in relation to certain birth defects.

S. Shapiro, M. Werler, A. Mitchell, 1987, The New England journal of medicine.

Management of Acute Otitis Media by Primary Care Physicians: Trends Since the Release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians Clinical Practice Guideline

A. Mitchell, R. Vezina, L. Vernacchio, 2007, Pediatrics.

Signal generation and clarification: use of case–control data

A. Mitchell, D. Kaufman, L. Rosenberg, 2001, Pharmacoepidemiology and drug safety.

Asthma morbidity after the short-term use of ibuprofen in children.

A. Mitchell, R. Vezina, S. Lesko, 2002, Pediatrics.

Teratogenicity of high vitamin A intake.

M. Werler, A. Mitchell, E. Lammer, 1996, The New England journal of medicine.

Medications as a potential source of exposure to phthalates among women of childbearing age.

S. Hernández-Díaz, A. Mitchell, A. Calafat, 2013, Reproductive toxicology.

Trends in first-trimester nausea and vomiting of pregnancy and use of select treatments: Findings from the National Birth Defects Prevention Study.

M. Werler, A. Mitchell, S. E. Parker, 2020, Paediatric and perinatal epidemiology.

Risk of Spina Bifida and Maternal Cigarette, Alcohol, and Coffee Use during the First Month of Pregnancy

M. Werler, A. Mitchell, M. Yazdy, 2013, International journal of environmental research and public health.

Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias.

M. Werler, A. Mitchell, A. Correa, 2008, Birth defects research. Part A, Clinical and molecular teratology.

Case‐Control Study of Vitamin Supplementation and Neural Tube Defects Consideration of Potential Confounding by Lifestyle Factors a

M. Werler, A. Mitchell, 1993, Annals of the New York Academy of Sciences.

More on folic acid and neural tube defects.

M. Werler, A. Mitchell, 1995, American Journal of Public Health.

Post‐marketing surveillance using pharmacy‐based cohorts: results of a pilot study

A. Mitchell, C. Louik, 2005, Pharmacoepidemiology and drug safety.

Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.

M. Werler, A. Mitchell, S. E. Parker, 2019, Birth defects research.

Folic Acid Intake and Spina Bifida in the Era of Dietary Folic Acid Fortification

M. Werler, A. Mitchell, M. Yazdy, 2011, Epidemiology.

Antihistamine Use in Early Pregnancy and Risk of Birth Defects

S. Hernández-Díaz, M. Werler, A. Mitchell, 2013 .

Correcting for exposure misclassification using survival analysis with a time-varying exposure.

M. Werler, A. Mitchell, T. Lash, 2012, Annals of epidemiology.

Smoking and warfarin dosage.

A. Mitchell, 1972, The New England journal of medicine.

Systematic identification of drugs that cause birth defects--a new opportunity.

A. Mitchell, Allen A Mitchell, 2003, The New England journal of medicine.

Practice of Epidemiology Sensitivity and Specificity of Computerized Algorithms to Classify Gestational Periods in the Absence of Information on Date of Conception

S. Hernández-Díaz, M. Werler, A. Mitchell, 2022 .

Increasing use of ADHD medications in pregnancy

A. Mitchell, Katherine E. Kelley, C. Louik, 2015, Pharmacoepidemiology and drug safety.

Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.

A. Mitchell, W. Bobo, J. Reefhuis, 2020, JAMA psychiatry.

Acute hypothermia associated with atropine.

A. Mitchell, F. Lovejoy, P. Lacouture, 1983, American journal of diseases of children.

Comment: Patterns of Isotretinoin Prescribing

A. Mitchell, 1992, The Annals of Pharmacotherapy.

Are cyclooxygenase-2 inhibitors being taken only by those who need them?

A. Mitchell, D. Kaufman, L. Rosenberg, 2005, Archives of internal medicine.

Tdap Vaccination Coverage During Pregnancy — Selected Sites, United States, 2006–2015

A. Mitchell, Stephen M Kerr, Carla M Van Bennekom, 2017, MMWR. Morbidity and mortality weekly report.

Accidental administration of ergonovine to a newborn.

A. Mitchell, P. Lacouture, R. Crone, 1983, JAMA.

Studies of Drug‐Induced Birth Defects

A. Mitchell, 2007 .

Original research article Antibiotics and oral contraceptive failure — a case-crossover study ☆

S. Hernández-Díaz, A. Mitchell, S. Toh, 2010 .

Maternal dietary glycaemic intake during pregnancy and the risk of birth defects.

M. Werler, A. Mitchell, Simin Liu, 2011, Paediatric and perinatal epidemiology.

Xylitol to prevent acute otitis media.

A. Mitchell, L. Vernacchio, 2007, The Pediatric infectious disease journal.

Toh et al. Respond to “Compromise or Compromising?”

S. Hernández-Díaz, M. Werler, A. Mitchell, 2007 .

Commentary on: "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12".

A. Mitchell, R. Xu, C. Chambers, 2017, Vaccine.

Risk factors for neonatal hyperglycemia associated with 10% dextrose infusion.

S. Shapiro, A. Mitchell, C. Louik, 1985, American journal of diseases of children.

Risk Factors for Persistent Pulmonary Hypertension of the Newborn

S. Hernández-Díaz, M. Werler, A. Mitchell, 2007, Pediatrics.

Fetal risk from ACE inhibitors in the first trimester

A. Mitchell, 2011, BMJ : British Medical Journal.

Hemodialysis in an infant with propoxyphene intoxication

A. Mitchell, F. Lovejoy, 1975, Clinical pharmacology and therapeutics.

Intracytoplasmic sperm injection: offering hope for a term pregnancyand a healthy child?

A. Mitchell, A. Mitchell, Allen A Mitchell, 1997, BMJ.

An application of data mining to identify potential risk factors for anophthalmia and microphthalmia

G. Shaw, A. Mitchell, A. Lin, 2018, Paediatric and perinatal epidemiology.

Selection bias and the use of controls with malformations in case-control studies of birth defects.

A. Olshan, M. Werler, A. Mitchell, 1999, Epidemiology.

Immunization surveillance systems for pregnant women

A. Mitchell, C. Chambers, M. Schatz, 2015, Pharmacoepidemiology and drug safety.

Birth Defects Related to Bendectin Use in Pregnancy. I. Oral Clefts and Cardiac Defects

S. Shapiro, A. Mitchell, L. Rosenberg, 1981 .

Use of vasoactive medications in pregnancy and the risk of stillbirth among birth defect cases

M. Werler, A. Mitchell, M. Yazdy, 2022, Birth defects research.

Comments on: Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin

A. Mitchell, Carla M Van Bennekom, 2014, Pharmacoepidemiology and drug safety.

Can folic acid protect against congenital heart defects in Down syndrome?

S. Hernández-Díaz, M. Werler, A. Mitchell, 2006, Birth defects research. Part A, Clinical and molecular teratology.

Acetaminophen and aspirin. Prescription, use, and accidental ingestion among children.

S. Shapiro, A. Mitchell, F. Lovejoy, 1982, American journal of diseases of children.

Guidelines for Good Epidemiology Practices for Drug, Device, and Vaccine Research in the United States

A. Mitchell, J. Avorn, B. Strom, 1996, Pharmacoepidemiology and drug safety.

Are hydantoins (phenytoins) human teratogens.

S. Shapiro, A. Mitchell, V. Siskind, 1977, The Journal of pediatrics.

Validity of maternal recall of gestational age and weight at birth: Comparison of structured interview and medical records

M. Werler, A. Mitchell, Carla M Van Bennekom, 2018, Pharmacoepidemiology and drug safety.

Case–control studies for identifying novel teratogens

M. Werler, A. Mitchell, C. Louik, 2011, American journal of medical genetics. Part C, Seminars in medical genetics.

Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.

M. Hernán, S. Hernández-Díaz, M. Werler, 2002, American journal of epidemiology.

Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study

M. Werler, A. Mitchell, T. Burns, 2021, BMJ Open.

Impact of Periconceptional Use of Nitrosatable Drugs on the Risk of Neural Tube Defects.

M. Werler, A. Mitchell, M. Yazdy, 2015, American journal of epidemiology.

Original Contribution Impact of Periconceptional Use of Nitrosatable Drugs on the Risk of Neural Tube Defects

M. Werler, A. Mitchell, M. Yazdy, 2015 .

Neural tube defects in relation to use of folic acid antagonists during pregnancy.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2001, American journal of epidemiology.

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2007, The New England journal of medicine.

Principles and considerations for effective academia‐industry collaboration in pharmacoepidemiology

A. Mitchell, T. Stürmer, W. Straus, 2018, Pharmacoepidemiology and Drug Safety.

Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2011, American journal of obstetrics and gynecology.

Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018

S. Hernández-Díaz, M. Werler, A. Mitchell, 2023, Clinical pharmacology and therapeutics.

Nausea and vomiting in pregnancy: maternal characteristics and risk factors.

S. Hernández-Díaz, M. Werler, A. Mitchell, 2006, Paediatric and Perinatal Epidemiology.

Predictors of recall certainty of dates of analgesic medication use in pregnancy

M. Werler, A. Mitchell, Rose G. Radin, 2013, Pharmacoepidemiology and drug safety.

A telephone intervention to achieve differentiation in dietary intake: a randomized trial in paediatric primary care

A. Mitchell, C. Ebbeling, C. Fischer, 2017, Pediatric obesity.

Maternal tea consumption during early pregnancy and the risk of spina bifida.

M. Werler, A. Mitchell, L. Demmer, 2012, Birth defects research. Part A, Clinical and molecular teratology.

Analyses and reanalyses of epidemiologic data: learning lessons and maintaining perspective.

S. Shapiro, M. Werler, A. Mitchell, 1992, Teratology.

A response to the commentary "Should we consider a subject's knowledge of the etiologic hypothesis in the analysis of case-control studies"?

S. Shapiro, M. Werler, A. Mitchell, 1995, American journal of epidemiology.